Insider Trading activities of Seattle Genetics Inc /wa insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seattle Genetics Inc /wa since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seattle Genetics Inc /wa since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Seattle Genetics Inc /wa since 2005. The reporting company's ticker symbol is SGEN. The reporting company's CIK number is 1060736.
The total value of stock buying since 2005 is $1,202,514,629.
The total value of stock sales since 2005 is $256,265,542.
The total value of stock option exercises since 2005 is $47,498,138.



Table 2. Detailed insider stock purchases, sales, and option exercises of Seattle Genetics Inc /wa insiders (SGEN) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-04-25 Dobmeier Eric (Chief Operating Officer) Sale 25,000 19.95 498,750
2012-04-25 Dobmeier Eric (Chief Operating Officer) Option Ex 25,000 10.24 256,124
2012-04-20 Rosenberg Morris (EVP, Process Sciences) Sale 38,281 19.51 746,862
2012-04-20 Rosenberg Morris (EVP, Process Sciences) Option Ex 38,281 5.63 215,522
2012-04-17 Rosenberg Morris (EVP, Process Sciences) Sale 44,219 18.88 834,854
2012-04-17 Rosenberg Morris (EVP, Process Sciences) Option Ex 44,219 5.82 257,487
2012-03-22 Reynolds Thomas C (Chief Medical Officer) Sale 40,000 19.78 791,120
2012-03-22 Reynolds Thomas C (Chief Medical Officer) Option Ex 40,000 8.24 329,600
2012-03-19 Reynolds Thomas C (Chief Medical Officer) Sale 37,700 19.75 744,575
2012-03-19 Reynolds Thomas C (Chief Medical Officer) Option Ex 37,700 8.24 310,648
2012-03-19 Lippman Marc E (Director) Option Ex 7,500 4.97 37,275
2012-03-16 Reynolds Thomas C (Chief Medical Officer) Sale 2,300 19.75 45,425
2012-03-16 Reynolds Thomas C (Chief Medical Officer) Option Ex 2,300 8.24 18,952
2012-03-13 Rosenberg Morris (EVP, Process Sciences) Sale 69,626 18.59 1,294,138
2012-03-13 Rosenberg Morris (EVP, Process Sciences) Option Ex 69,626 7.35 511,890
2012-02-28 Dobmeier Eric (Chief Operating Officer) Sale 46,000 18.52 851,920
2012-02-28 Dobmeier Eric (Chief Operating Officer) Option Ex 46,000 10.27 472,190
2012-01-27 Reynolds Thomas C (Chief Medical Officer) Sale 40,000 19.75 790,000
2012-01-27 Reynolds Thomas C (Chief Medical Officer) Option Ex 40,000 8.24 329,600
2012-01-03 Siegall Clay B (President and CEO) Sale 15,000 16.73 250,965
2012-01-03 Siegall Clay B (President and CEO) Option Ex 15,000 6.34 95,100
2011-12-22 Dobmeier Eric (Chief Operating Officer) Option Ex 10,000 4.45 44,500
2011-12-15 Gryska David W (Director) Option Ex 4,500 5.00 22,500
2011-12-14 Lippman Marc E (Director) Option Ex 6,875 6.40 44,000
2011-12-09 Gryska David W (Director) Sale 10,000 18.09 180,920
2011-12-01 Siegall Clay B (President and CEO) Sale 15,000 15.97 239,595
2011-12-01 Siegall Clay B (President and CEO) Option Ex 15,000 6.34 95,100
2011-11-09 Dobmeier Eric (Chief Operating Officer) Option Ex 2,516 5.25 13,209
2011-11-01 Siegall Clay B (President and CEO) Sale 15,000 21.89 328,410
2011-11-01 Siegall Clay B (President and CEO) Option Ex 15,000 6.34 95,100
2011-10-27 Dobmeier Eric (Chief Operating Officer) Sale 20,918 21.95 459,150
2011-10-27 Dobmeier Eric (Chief Operating Officer) Option Ex 20,918 5.87 122,684
2011-10-20 Dobmeier Eric (Chief Operating Officer) Sale 20,461 20.58 421,025
2011-10-20 Dobmeier Eric (Chief Operating Officer) Option Ex 20,461 6.74 137,907
2011-10-07 Simpson Todd E (Chief Financial Officer) Sale 24,350 21.97 534,969
2011-10-07 Simpson Todd E (Chief Financial Officer) Option Ex 24,350 5.20 126,620
2011-10-04 Siegall Clay B (President and CEO) Sale 15,000 20.15 302,280
2011-10-04 Siegall Clay B (President and CEO) Option Ex 15,000 6.34 95,100
2011-09-21 Siegall Clay B (President and CEO) Sale 24,400 20.15 491,708
2011-09-21 Siegall Clay B (President and CEO) Option Ex 24,400 6.34 154,696
2011-09-20 Siegall Clay B (President and CEO) Sale 5,600 20.00 112,005
2011-09-20 Siegall Clay B (President and CEO) Option Ex 5,600 6.34 35,504
2011-09-09 Mclaughlin John Peter (Director) Option Ex 25,000 9.82 245,500
2011-09-06 Baker Felix (Director) Buy 130,960 17.11 2,241,118
2011-09-02 Siegall Clay B (President and CEO) Option Ex 16,251 3.30 53,628
2011-08-25 Baker Felix (Director) Buy 1,000,000 15.44 15,443,999
2011-08-24 Baker Felix (Director) Buy 9,723 14.98 145,630
2011-08-23 Baker Felix (Director) Buy 173,638 14.69 2,551,436
2011-07-18 Simpson Todd E (Chief Financial Officer) Option Ex 18,663 4.83 90,048
2011-07-01 Siegall Clay B (President and CEO) Sale 15,000 20.66 309,870
2011-07-01 Siegall Clay B (President and CEO) Option Ex 15,000 6.34 95,100
2011-06-22 Berger Franklin M (Director) Buy 7,000 20.04 140,273
2011-06-20 Dobmeier Eric (Chief Operating Officer) Sale 13,385 20.00 267,700
2011-06-20 Siegall Clay B (President and CEO) Sale 9,000 20.01 180,072
2011-06-20 Siegall Clay B (President and CEO) Option Ex 9,000 6.34 57,060
2011-06-09 Dobmeier Eric (Chief Business Officer) Sale 3,600 20.00 72,000
2011-06-09 Siegall Clay B (President and CEO) Sale 1,000 20.00 20,000
2011-06-09 Siegall Clay B (President and CEO) Option Ex 1,000 6.34 6,340
2011-06-07 Simpson Todd E (Chief Financial Officer) Sale 10,750 19.96 214,570
2011-06-07 Simpson Todd E (Chief Financial Officer) Option Ex 10,750 5.20 55,900
2011-06-07 Rosenberg Morris (EVP, Process Sciences) Sale 2,503 19.67 49,244
2011-06-07 Rosenberg Morris (EVP, Process Sciences) Option Ex 2,503 6.34 15,869
2011-05-27 Rosenberg Morris (EVP, Process Sciences) Sale 17,497 19.50 341,191
2011-05-27 Rosenberg Morris (EVP, Process Sciences) Option Ex 17,497 6.34 110,930
2011-05-19 Reynolds Thomas C (Chief Medical Officer) Sale 14,585 18.71 272,885
2011-05-19 Reynolds Thomas C (Chief Medical Officer) Option Ex 14,585 11.09 161,747
2011-05-19 Rosenberg Morris (EVP, Process Sciences) Sale 20,000 18.80 376,000
2011-05-19 Rosenberg Morris (EVP, Process Sciences) Option Ex 20,000 6.34 126,800
2011-05-18 Reynolds Thomas C (Chief Medical Officer) Sale 5,413 18.70 101,223
2011-05-18 Reynolds Thomas C (Chief Medical Officer) Option Ex 5,413 11.09 60,030
2011-05-18 Simpson Todd E (Chief Financial Officer) Sale 21,250 18.64 396,100
2011-05-18 Simpson Todd E (Chief Financial Officer) Option Ex 21,250 4.83 102,531
2011-05-18 Siegall Clay B (President and CEO) Option Ex 5,000 6.34 31,700
2011-05-13 Reynolds Thomas C (Chief Medical Officer) Sale 20,000 17.80 356,000
2011-05-13 Reynolds Thomas C (Chief Medical Officer) Option Ex 20,000 8.24 164,800
2011-05-13 Rosenberg Morris (EVP, Process Sciences) Sale 20,000 17.80 356,000
2011-05-13 Rosenberg Morris (EVP, Process Sciences) Option Ex 20,000 6.34 126,800
2011-05-13 Dobmeier Eric (Chief Business Officer) Sale 42,715 18.00 768,870
2011-05-13 Dobmeier Eric (Chief Business Officer) Option Ex 42,715 5.87 250,523
2011-05-09 Simpson Todd E (Chief Financial Officer) Sale 20,000 17.74 354,799
2011-05-09 Simpson Todd E (Chief Financial Officer) Option Ex 20,000 4.45 89,000
2011-05-09 Siegall Clay B (President and CEO) Sale 50,000 17.35 867,700
2011-05-09 Siegall Clay B (President and CEO) Option Ex 50,000 8.43 421,500
2011-05-02 Rosenberg Morris (EVP, Process Sciences) Sale 12,500 17.50 218,750
2011-05-02 Rosenberg Morris (EVP, Process Sciences) Option Ex 12,500 6.72 84,000
2011-05-02 Siegall Clay B (President and CEO) Sale 50,000 17.43 871,350
2011-05-02 Siegall Clay B (President and CEO) Option Ex 50,000 8.43 421,500
2011-04-29 Reynolds Thomas C (Chief Medical Officer) Sale 11,915 16.95 201,959
2011-04-29 Reynolds Thomas C (Chief Medical Officer) Option Ex 9,999 8.24 82,391
2011-04-29 Simpson Todd E (Chief Financial Officer) Sale 15,000 16.94 254,100
2011-04-29 Simpson Todd E (Chief Financial Officer) Option Ex 15,000 4.45 66,750
2011-04-29 Rosenberg Morris (EVP, Process Sciences) Sale 12,500 16.80 210,000
2011-04-29 Rosenberg Morris (EVP, Process Sciences) Option Ex 12,500 6.72 84,000
2011-04-14 Siegall Clay B (President and CEO) Sale 50,000 15.27 763,450
2011-04-14 Siegall Clay B (President and CEO) Option Ex 50,000 8.43 421,500
2011-04-07 Siegall Clay B (President and CEO) Sale 50,000 16.06 802,900
2011-04-07 Siegall Clay B (President and CEO) Option Ex 50,000 8.43 421,500
2011-04-05 Dobmeier Eric (Chief Business Officer) Sale 40,000 16.00 640,000
2011-04-05 Dobmeier Eric (Chief Business Officer) Option Ex 40,000 5.30 211,880
2011-03-17 Siegall Clay B (President and CEO) Sale 200,000 14.09 2,817,200
2011-03-17 Siegall Clay B (President and CEO) Option Ex 200,000 8.43 1,686,000
2011-02-02 Baker Felix (Director) Buy 1,800,000 15.50 27,899,999
2010-12-22 Dobmeier Eric (Chief Business Officer) Option Ex 4,000 5.25 21,000
2010-12-15 Rosenberg Morris (EVP, Process Sciences) Sale 25,000 16.22 405,500
2010-12-15 Rosenberg Morris (EVP, Process Sciences) Option Ex 25,000 6.72 168,000
2010-12-02 Rosenberg Morris (EVP, Process Sciences) Sale 25,000 15.81 395,150
2010-12-02 Rosenberg Morris (EVP, Process Sciences) Option Ex 25,000 6.72 168,000
2010-11-12 Gryska David W (Director) Option Ex 4,000 5.00 20,000
2010-11-04 Rosenberg Morris (EVP, Process Sciences) Sale 25,000 14.70 367,400
2010-11-04 Rosenberg Morris (EVP, Process Sciences) Option Ex 25,000 6.72 168,000
2010-10-11 Reynolds Thomas C (Chief Medical Officer) Sale 25,000 16.95 423,750
2010-10-11 Reynolds Thomas C (Chief Medical Officer) Option Ex 25,000 8.24 206,000
2010-10-01 Berger Franklin M (Director) Option Ex 5,000 8.38 41,900
2010-09-27 Reynolds Thomas C (Chief Medical Officer) Sale 25,000 14.95 373,750
2010-09-27 Reynolds Thomas C (Chief Medical Officer) Option Ex 25,000 8.24 206,000
2010-08-31 Siegall Clay B (President & CEO) Option Ex 48,332 3.00 144,996
2010-08-24 Berger Franklin M (Director) Option Ex 13,000 7.71 100,165
2010-06-21 Akkaraju Srinivas (Director) Option Ex 50,000 7.37 368,300
2010-06-08 Baker Felix (Director) Buy 500,000 11.94 5,968,999
2010-06-07 Baker Felix (Director) Buy 115,605 11.88 1,373,964
2010-06-04 Lippman Marc E (Director) Buy 20,000 12.49 249,840
2010-05-25 Baker Felix (Director) Buy 5,566 11.95 66,513
2010-05-14 Berger Franklin M (Director) Option Ex 17,000 7.03 119,510
2010-05-13 Berger Franklin M (Director) Buy 5,000 13.37 66,865
2010-05-10 Lippman Marc E (Director) Buy 11,075 11.92 131,991
2010-05-04 Baker Felix (Director) Buy 358,366 12.71 4,554,114
2010-05-03 Reynolds Thomas C (Chief Medical Officer) Sale 25,000 12.95 323,750
2010-05-03 Reynolds Thomas C (Chief Medical Officer) Option Ex 23,203 8.24 191,192
2010-05-03 Baker Felix (Director) Buy 218,849 12.87 2,815,929
2010-04-30 Baker Felix (Director) Buy 314,469 12.63 3,971,113
2010-04-20 Siegall Clay B (President and CEO) Option Ex 20,000 3.00 60,000
2010-03-30 Berger Franklin M (Director) Buy 11,500 12.05 138,529
2010-03-12 Berger Franklin M (Director) Buy 5,000 11.76 58,795
2010-03-10 Berger Franklin M (Director) Buy 8,000 11.99 95,920
2010-02-17 Gryska David W (Director) Option Ex 4,000 4.18 16,720
2009-12-29 Berger Franklin M (Director) Option Ex 10,000 5.11 51,100
2009-12-02 Hoth Daniel Floyd Jr (Director) Option Ex 10,405 5.06 52,649
2009-10-29 Dobmeier Eric (Chief Business Officer) Option Ex 6,985 4.85 33,877
2009-10-07 Berger Franklin M (Director) Option Ex 5,000 4.18 20,900
2009-09-08 Siegall Clay B (President and CEO) Option Ex 10,000 3.00 30,000
2009-08-18 Akkaraju Srinivas (Director) Buy 4,905 11.47 56,260
2009-08-11 Baker Felix (Director) Buy 1,880,000 10.75 20,209,999
2009-07-30 Reynolds Thomas C (Chief Medical Officer) Sale 25,000 12.47 311,725
2009-07-30 Reynolds Thomas C (Chief Medical Officer) Option Ex 25,000 8.24 206,000
2009-07-30 Dobmeier Eric (Chief Business Officer) Sale 33,734 12.36 417,053
2009-07-30 Dobmeier Eric (Chief Business Officer) Option Ex 33,734 5.04 170,019
2009-07-29 Berger Franklin M (Director) Option Ex 5,000 4.18 20,900
2009-07-29 Dobmeier Eric (Chief Business Officer) Sale 26,266 12.36 324,752
2009-07-29 Dobmeier Eric (Chief Business Officer) Option Ex 19,266 4.76 91,706
2009-07-28 Rosenberg Morris (EVP, Development) Sale 25,000 11.81 295,250

Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seattle Genetics Inc /wa (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.